Q1 2017 TESARO Inc Earnings Call

9/5/2017 16:15

Conference Call TESARO Inc

TESARO Inc Conference call or earnings call will be held on May 9, 2017
During the earnings conference call’s session, TESARO Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact TESARO Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. We were founded in March 2010 and have in-licensed and are developing oncology-related product candidates, including rolapitant and niraparib, as well as product candidates under our immuno-oncology platform. On September 1, 2015, our first commercial product, VARUBI® (rolapitant), was approved by the United States Food and Drug Administration, or FDA, for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited 4 -------------------------------------------------------------------------------- Table of Contents to, highly emetogenic chemotherapy.    
Read more Conference Call

TESARO Inc (TSRO)

1000 Winter Street, Waltham Massachusetts 02451, United States